Valuation : InterCure Ltd.

Market Cap 193M 0 166M 156M 142M 268M 18.44B 269M 1.85B 721M 9.31B 724M 709M 30.86B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 329M 0 284M 266M 243M 457M 31.47B 459M 3.16B 1.23B 15.88B 1.24B 1.21B 52.67B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+3.10%
1 week+34.55%
Current month+12.00%
1 month+27.50%
3 months-1.73%
6 months+33.43%
Current year+9.02%
1 week 1,515
Extreme 1515
1,862
1 month 1,255
Extreme 1255
1,862
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,834.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 24/12/2019
Director of Finance/CFO 47 01/03/2020
General Counsel - 01/04/2022
Director TitleAgeSince
Director/Board Member 50 03/09/2015
Director/Board Member 66 14/12/2014
Chairman 55 13/02/2025
Date Insider Type Main position Quantity % Market Cap.
18/3/26 Other

Chief Financial Officer

539,947 0.9874%
18/3/26 Other

Director

19,046 0.0348%
18/3/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
+3.10%+34.55%-34.26%-34.79% 64.74M
+1.75%+6.99%-11.01%+277.92% 356M
0.00%-1.75%-28.81%-13.40% 170M
-0.50%0.00%+10.56%+89.52% 141M
-6.98%-14.89%-52.38%-29.82% 81.29M
Average -0.53%+4.98%-23.18%+57.89% 162.72M
Weighted average by Cap. +0.23%+3.95%-16.97%+128.58%

Financials

2024 2025
Net sales 239M 0 206M 193M 176M 332M 22.83B 333M 2.29B 893M 11.52B 897M 877M 38.21B 270M 0 233M 218M 199M 375M 25.82B 377M 2.59B 1.01B 13.04B 1.01B 992M 43.22B
Net income -67.8M -0 -58.42M -54.77M -50M -94.19M -6.48B -94.49M -650M -254M -3.27B -255M -249M -10.85B -35.71M -0 -30.77M -28.85M -26.34M -49.61M -3.41B -49.77M -342M -134M -1.72B -134M -131M -5.71B
Net Debt 133M 0 114M 107M 97.91M 184M 12.69B 185M 1.27B 496M 6.4B 498M 488M 21.24B 136M 0 117M 110M 101M 189M 13.03B 190M 1.31B 510M 6.58B 512M 501M 21.81B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
28/08/26 ILA 1,764.00 +3.10% 33,737
27/08/26 ILA 1,711.00 -3.28% 6,593
26/08/26 ILA 1,769.00 +2.85% 56,087
25/08/26 ILA 1,720.00 +9.00% 142,752
24/08/26 ILA 1,578.00 +20.37% 246,635
  1. Stock Market
  2. Stocks
  3. INCR Stock